Literature DB >> 11096680

Restenosis and Hyperplasia: Animal Models.

.   

Abstract

Coronary restenosis after percutaneous interventions remains a major clinical problem even in the days of coronary stents. Understanding the pathophysiologic mechanisms and the assessment of therapies for the prevention of restenosis relies on experimental animal models. This article describes the most frequently used animal models of coronary artery restenosis and the differences among them. The variable response to injury in the different models should be considered in the interpretation of the effective therapies before they are transferred into clinical trials. The rat carotid model played an important role as a pioneer in animal models for restenosis but has failed to predict results of clinical restenosis. This lack of predictability highlights a fundamental lack of understanding of the basic molecular mechanisms that control vascular healing after injury.

Entities:  

Year:  2000        PMID: 11096680

Source DB:  PubMed          Journal:  Curr Interv Cardiol Rep        ISSN: 1523-3839


  3 in total

1.  Effects of Axial Stretch on Cell Proliferation and Intimal Thickness in Arteries in Organ Culture.

Authors:  Yong-Ung Lee; Danika Hayman; Eugene A Sprague; Hai-Chao Han
Journal:  Cell Mol Bioeng       Date:  2010-09-01       Impact factor: 2.321

2.  Complex porcine model of atherosclerosis: induction of early coronary lesions after long-term hyperlipidemia without sustained hyperglycemia.

Authors:  Sandra Artinger; Carolin Deiner; Christoph Loddenkemper; Peter L Schwimmbeck; Heinz-Peter Schultheiss; Klaus Pels
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

Review 3.  Development of a rabbit model for a preclinical comparison of coronary stent types in-vivo.

Authors:  Joo Myung Lee; Jaewon Lee; Heewon Jeong; Won Seok Choe; Won-Woo Seo; Woo-Hyun Lim; Young-Chan Kim; Jin Hur; Sang Eun Lee; Han-Mo Yang; Hyun-Jai Cho; Hyo-Soo Kim
Journal:  Korean Circ J       Date:  2013-11-30       Impact factor: 3.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.